Waverley Pharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WAVERLEY PHARMA INC, and what generic and branded alternatives to WAVERLEY PHARMA INC drugs are available?
WAVERLEY PHARMA INC has two approved drugs.
Drugs and US Patents for Waverley Pharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Waverley Pharma Inc | BORTEZOMIB | bortezomib | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 211898-001 | Oct 11, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Waverley Pharma Inc | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 211899-001 | May 25, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Waverley Pharma Inc | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 211899-002 | May 25, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.